2013 亞洲地區乳癌學術交流論壇
Breast Cancer Academic Exchange Forum for Asia
Saturday, Sep. 14, 2013
Time
Topic
09:00
Welcome Remarks
Speaker
Chiun-Sheng Huang
海峽兩岸乳癌治療交流
09:10
09:30
Recent Advance in Target Therapy
09:30 海峽兩岸乳癌
治療交流
09:50
09:50
10:10
10:10
10:30
Anthracycline-related Biomarker - New Understanding
Jin Zhang
(張瑾)
about TOP2A
Wang Jiayu
(王佳玉)
Optimal use of Anthracycline with the emergence of
evidences
Ta-Chung Chao
(趙大中)
Coffee Break
Session 1
Breast Surgery and Axillary Staging
10:30
10:50
10:50
11:10
11:10
11:40
海峽兩岸乳癌
治療交流
Moderator
High Resolution Ultrasound in Differential Diagnosis of
Regional Lymph node metastasis in Breast Cancer
Wen-Hung
Kuo
(郭文宏)
Clinical Study of Internal Mammary Sentinel Lymph Node
Biopsy in Breast Cancer Patients
Yong-Sheng
Wang
(王永勝)
The Dilemma of Occult Axillary Metastases
Peter William
Blumencranz
11:40
Dar-Ren Chen
The Initial Experiences In Breast Cancer Surgery With The PEAK PlasmaBlade
(陳達人)
12:00
Lunch & Lecture
12:00 Endocrine Suppression Studies for Premenopausal Women with HR+ Breast
13:00
Cancer in Korea
Hee Jeong
Kim
Session 2
Management of ER Positive and Her-2 Negative Metastatic Breast Cancer
13:00
13:40
Non-canonical EGFR Pathways in Breast Cancer
Mien-Chie
Hung
13:40 Management of ER Positive, Her-2 Negative Breast Cancer, Optimal Use
Sung-Bae Kim
14:05 of Chemotherapy and Options of Hormonal Therapy after Tamoxifen and AI
14:05
14:40
The Mechanisms of Endocrine Therapy Resistance and New Strategies for
an Evolving Disease
Matti Aapro
14:40
15:00
Integrating Clinical Evidence of PI3K/AKT/mTOR Pathway into the
HR+/HER2- Advanced Breast Cancer Landscape
Ling-Ming
Tseng
(曾令民)
15:00
15:20
Coffee Break
Session 3
Management of Her-2 Positive Cancer
15:20
16:10
From Bench to Bedside: From the Discovery of HER2 and the Rational
Development of Trastuzumab to
Current and Upcoming Approaches in the Adjuvant and Neoadjuvant
Settings
Dennis
Slamon
16:10
16:40
Innovations in the treatment of HER2+ advanced breast cancer: 2013
Sara Hurvitz
16:40
17:05
Strategic Approaches to the Treatment of Hormone Receptor-positive,
HER2-positive Metastatic Breast Cancer: Is Chemotherapy a Must?
Ching-Hung
Lin
(林璟宏)
Session 4
New devewlopment in Management of Metastatic breast cancer
17:05
17:35
17:35
18:00
Cancer immunotherapy –the present and the future
CTC-Based Diagnostics for Guiding Implementation of Targeted
Treatments in Cancer
Alice Yu
(陳鈴津)
Hsian-Rong
Tseng
2013 亞洲地區乳癌學術交流論壇
Breast Cancer Academic Exchange Forum for Asia
Sunday, Sep. 15, 2013
Session 4
New devewlopment in Management of Metastatic Breast Cancer
08:30
08:55
08:55
Overall survival: Is a possible end point to be achieved in MBC
Adequate Duration of Bevacizumab Preconditioning Induces Better
Toshiaki Saeki
Yen-Shen Lu
(盧彥伸)
09:15
Vascular Normalization and Significantly Improves the Efficacy of
Chemotherapy against Metastatic Breast Cancer
09:15
09:45
New Insights on the Biology and Treatment of Breast Cancer Brain
Metastasis
Di-Hua Yu
Breast Cancer with Brain Metastasis
Hwei-Chung
Wang
(王惠暢)
09:45
10:10
10:10
10:30
Coffee Break
Session 5
Controversy in adjuvant therapy
10:30
11:00
Using Ki67/ IHC4 or Multigene Assay, Oncotype DX or Mammaprint, for
Personalized Treatment - A Pathologist's Viewpoint
Frederique
Penault-Llorca
11:00
11:25
The Level of Evidence of IHC4, Oncotype DX and Mammaprint in
Predicting Who Needs Adjuvant Chemotherapy
Chee Khoon Lee
11:25
11:45
11:45
12:15
Small Tumor, Bad Prognosis in Lymph Node Negative Breast Cancer
Kun-Ming Rau
(饒坤銘)
Adjuvant Therapy for ER-Positive Early Breast Cancer
Christina Davies
Luncheon Symposium
12:15
13:10
13:10
13:15
Management of HBV Reactivation During Cancer Chemotherapy
Paper Award
Chun-Jen Liu
(劉俊人)
Chiun-Sheng Huang
Session 5
Controversy in adjuvant therapy
13:15
13:40
Clinical Considerations of Hormone Therapy Strategy for Early Breast
Cancer – Perspectives from Japan
Masahiro
Kashiwaba
13:40
14:00
Integrating Bone-Modifying Agents into Treatment for Breast Cancer
Patients
Lang-Chih Liu
(劉良智)
14:00
14:30
What are Important in St. Gallen 2013
14:30
14:50
Masakazu Toi
Coffee Break
Session 6
Breast Imaging
14:50
15:20
15:20
15:45
15:45
16:10
16:10
16:30
16:30
Breast Screening Strategy for Asia
Breast Tomosynthesis: Is It a Better Option for Breast Cancer Screening
in Premenopausal Women?
Second-Look Sonography Using an Image Fusion Technique in Breast
Imaging
Automated Breast Ultrasound Screening: Toward StandarDization
Closing
Xiu-Xi Chen
(陳秀熙)
Visnja Baksa
Reynolds
Shogo Nakano
Ruey-Feng Chang
(張瑞峰)
Chiun-Sheng Huang
Nursing Care for Breast Cancer
Saturday, September 14, 2013
Room31
Time
Topic
Speaker
13:00
|
13:30
整合乳癌病人照護品質
許麗珠主任
和信治療中心醫院
13:30
|
14:00
14:00
|
14:40
Integrating Quality in Breast Cancer Care
初診斷乳癌婦女及其壓力之感受
Stress Perception among Women with Newly
Diagnosed Breast Cancer
李作英副主任
振興醫院護理部
乳癌與憂鬱症關係之系統性文獻回顧
黃三原醫師
The Relationship Between Breast Cancer and
Depression Disorder- A Systematic Review
運用皮質醇、睡眠、身心狀況預測乳癌病人罹患
三軍總醫院
精神醫學部
Moderator
曾雯琦
三軍總醫院
陳美伶
憂鬱症狀之長期性追蹤
14:40
|
15:10
15:10
|
15:30
15:30
|
16:00
16:00
|
16:30
Cortisol Responses, Sleep Problems, and
Psychological Well-being as the Predictors of
Changes in Depressive Symptoms among Breast
Cancer Survivors
長庚大學
蕭妃秀副教授
台大醫學院護理學系
Break
乳房重建後的生活品質
Quality of life after breast reconstruction surgery.
癌因性疲憊與發炎前細胞激素之關係
The Relationship of Cancer-related Fatigue and
Proinflammtory Cytokines
16:30
|
17:00
改善乳癌婦女癌因性疲憊之可行策略
17:00
|
17:30
乳癌末期病人之安寧療護
Interventions for the Management of
Cancer-related Fatigue
Hospice Care for Patients Dying with Breast Cancer
林佳佑
長庚醫院研究員
周繡玲副主任
亞東醫院護理部
孫秀卿副教授
台大醫學院護理學系
潘雪幸博士
三軍總醫院護理部
蔡麗雲
台北馬階醫
院
陳美碧
台北榮民總
醫院